图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
肿瘤形成评论综述™
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN 打印: 0893-9675
ISSN 在线: 2162-6448

肿瘤形成评论综述™

DOI: 10.1615/CritRevOncog.2014011815
pages 247-260

Progress in Lipid-Based Nanoparticles for Cancer Therapy

Sarina Grinberg
Department of Chemistry, Ben-Gurion University of the Negev, Israel
Charles Linder
Zuckerberg Water Institute and Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Israel
Eliahu Heldman
Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Israel

ABSTRACT

Most conventional cancer therapeutics gain limited access to many types of tumors while having considerable adverse effects, resulting in low therapeutic efficacy and high toxicity. Therefore, research has now focused on the development of novel drug delivery systems (DDS) with the goal of maintaining high therapeutic drug levels at malignant cells and as low as possible drug levels in other cells. The introduction of nanotechnology has addressed some of these problems and opened up new avenues for improved cancer therapy. The design of nanoparticles for DDS takes into consideration issues such as targeting, controlled drug release and enhanced penetration via biological barriers. In this review we describe the design principles of targeted DDS for cancer therapy and the types of nanoparticles that are under development. Emphasis is put on lipid-based nanoparticles, particularly bolaamphiphilic vesicles that have tremendous potential in delivering therapeutic and diagnostic agents to specific cells following systemic administration.


Articles with similar content:

Photoimmunotherapy for Cancer Treatment
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Mladen Korbelik, Zheng Huang, Robert E. Nordquist, Hong Liu, Wei R. Chen
Role of Block Copolymer Nanoconstructs in Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 2
H. G. Agrawal, K. K. Upadhyay, C. Schatz, Sebastian Lecommandoux, J. F. Le Meins, Ambikanandan Misra, C. Upadhyay
Pulmonary Drug Delivery Systems: Recent Developments and Prospects
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.19, 2002, issue 4-5
Th. F. Vandamme, N. Butz, H. M. Courrier
Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 1
Preshita Desai, Jeffrey Wang, Sunil Prabhu, David Ann
Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 5
Shivani Saraf, Ankit Jain, Pooja Hurkat, Sanjay Kumar Jain